Insight Pt. 1: Innovations in Treating Heart Disease in Women

Heart disease is the leading cause of death for women in the United States, yet too many women remain undiagnosed or receive treatment later than they should. On this episode, we welcome David St. Denis, President of Anteris Technologies, for an important conversation about women and heart valve disease, why outcomes can differ between men and women, and how innovation may help improve the future of cardiovascular care. We discuss aortic stenosis, the symptoms women should never ignore, the importance of early diagnosis, and the development of the investigational DurAVR® Transcatheter Heart Valve, a next-generation technology designed to better mimic the function of a healthy heart valve.David also explains why greater representation of women in clinical research is essential and shares practical advice on how women can become stronger advocates for their heart health. Whether you're looking to learn more about heart disease prevention, caring for a loved one, or staying informed about the latest advances in cardiovascular medicine, this conversation offers valuable insights that could make a lifesaving difference. ResourcesAnteris TechnologiesDurAVR® Clinical EvidenceAnteris News & Investor CenterAmerican Heart Association – Go Red for WomenCDC – Heart Disease in WomenFollow Anteris TechnologiesLinkedInX (Twitter) – @AnterisTechDurAVR® is an investigational device and is not available for commercial sale. Discussion of the technology reflects ongoing research and clinical development.